MK2a Inhibitor,
CMPD-1,
41179-33-3,
MAPKAPK2a Inhibitor,
CMPD1,
CHEMBL235658,
2'-FLUORO-N-(4-HYDROXYPHENYL)-[1,1'-BIPHENYL]-4-BUTANAMIDE,
4-(2'-Fluoro-[1,1'-biphenyl]-4-yl)-N-(4-hydroxyphenyl)butanamide,
4-(2′-Fluorobiphenyl-4-yl)-N-(4-hydroxyphenyl)-butyramide,
Mitogen-activated protein kinase-activated protein kinase 2a Inhibitor,
MK2a Inhibitor_x000D_,
SCHEMBL169905,
GTPL6009,
CHEBI:92949,
CTK8G1136,
DTXSID60464220,
4-[4-(2-fluorophenyl)phenyl]-N-(4-hydroxyphenyl)butanamide,
HMS3229K04,
HMS3268P13,
HMS3677K11,
ZINC7992846,
BDBM50411445,
BS0053,
IN1225,
AKOS024456977,
CCG-206869,
ACM41179333,
NCGC00092325-01,
B6962,
BRD-K54095730-001-01-5,
4179-33-3,
D0O7UT,
CID11382492,
A16040,